A citation-based method for searching scientific literature

B B Roa, A A Boyd, K Volcik, C S Richards. Nat Genet 1996
Times Cited: 543

A C Antoniou, A P Cunningham, J Peto, D G Evans, F Lalloo, S A Narod, H A Risch, J E Eyfjord, J L Hopper, M C Southey, H Olsson, O Johannsson, A Borg, B Pasini, P Radice, S Manoukian, D M Eccles, N Tang, E Olah, H Anton-Culver, E Warner, J Lubinski, J Gronwald, B Gorski, L Tryggvadottir, K Syrjakoski, O-P Kallioniemi, H Eerola, H Nevanlinna, P D P Pharoah, D F Easton. Br J Cancer 2008
Times Cited: 299

List of shared articles

Times cited

Statistical approaches for meta-analysis of genetic mutation prevalence.
Margaux L A Hujoel, Giovanni Parmigiani, Danielle Braun. Genet Epidemiol 2021

Population-based genetic testing for Women's cancer prevention.
Olivia Evans, Faiza Gaba, Ranjit Manchanda. Best Pract Res Clin Obstet Gynaecol 2020

Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank.
Noura S Abul-Husn, Emily R Soper, Jacqueline A Odgis, Sinead Cullina, Dean Bobo, Arden Moscati, Jessica E Rodriguez, Ruth J F Loos, Judy H Cho, Gillian M Belbin,[...]. Genome Med 2019

Linking uterine serous carcinoma to BRCA1/2-associated cancer syndrome: A meta-analysis and case report.
M M de Jonge, A L Mooyaart, M P G Vreeswijk, C D de Kroon, T van Wezel, C J van Asperen, V T H B M Smit, O M Dekkers, T Bosse. Eur J Cancer 2017

Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.
Kelly-Anne Phillips, Ian M Collins, Roger L Milne, Sue Anne McLachlan, Michael Friedlander, Martha Hickey, Catharyn Stern, John L Hopper, Richard Fisher, Gordon Kannemeyer,[...]. Hum Reprod 2016

Breast Cancer: Genetics and Risk Assessment.
Trevor Tejada-Bergés. Clin Obstet Gynecol 2016